BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 24566414)

  • 1. Isolated nasal tip metastasis from esophageal squamous cell carcinoma.
    Dong A; Zuo C; Wang Y; Zhai Z; Wen W
    Clin Nucl Med; 2015 Jan; 40(1):65-7. PubMed ID: 24566414
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nasal-Tip Metastasis on 18F-FDG PET/CT Scan in a Patient With Squamous Lung Carcinoma.
    Fu Z; Liu M; Zhang J; Li Z; Li Q
    Clin Nucl Med; 2017 Jun; 42(6):478-479. PubMed ID: 28240659
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of the diagnostic value of 3-deoxy-3-18F-fluorothymidine and 18F-fluorodeoxyglucose positron emission tomography/computed tomography in the assessment of regional lymph node in thoracic esophageal squamous cell carcinoma: a pilot study.
    Han D; Yu J; Zhong X; Fu Z; Mu D; Zhang B; Xu G; Yang W; Zhao S
    Dis Esophagus; 2012 Jul; 25(5):416-26. PubMed ID: 21951837
    [TBL] [Abstract][Full Text] [Related]  

  • 4. F-18 FDG PET/CT contributes to more accurate detection of lymph nodal metastasis from actively proliferating esophageal squamous cell carcinoma.
    Tanabe S; Naomoto Y; Shirakawa Y; Fujiwara Y; Sakurama K; Noma K; Takaoka M; Yamatsuji T; Hiraki T; Okumura Y; Mitani M; Kaji M; Kanazawa S; Fujiwara T
    Clin Nucl Med; 2011 Oct; 36(10):854-9. PubMed ID: 21892033
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patterns of nodal metastases on 18F-FDG PET/CT in patients with esophageal squamous cell carcinoma are useful to guide treatment planning of radiotherapy.
    Liu CJ; Cheng JC; Lee JM; Cheng MF; Tzen KY; Yen RF
    Clin Nucl Med; 2015 May; 40(5):384-9. PubMed ID: 25674870
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bone Sequestration as a Consequence of Esophageal Carcinoma Metastasis Detected by 18F-FDG PET/CT.
    Cui F; Su M; Chen C; Tian R
    Clin Nucl Med; 2018 Nov; 43(11):846-847. PubMed ID: 30222678
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic value of metabolic tumor volume measured by 18F-fluorodeoxyglucose positron emission tomography in patients with esophageal carcinoma.
    Hyun SH; Choi JY; Shim YM; Kim K; Lee SJ; Cho YS; Lee JY; Lee KH; Kim BT
    Ann Surg Oncol; 2010 Jan; 17(1):115-22. PubMed ID: 19826877
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Radiation-Induced Esophagitis Masquerading as Disease Progression in Case of Esophageal Carcinoma: A Diagnostic Dilemma Solved on Follow-up FDG PET/CT.
    Mukherjee A; Chakraborty PS; Behera A; Bal C; Kumar R
    Clin Nucl Med; 2015 Jul; 40(7):e380-1. PubMed ID: 25706793
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Advantages of positron emission tomography-computed tomography imaging in esophageal squamous cell carcinoma.
    Wang F; Shen LY; Ma SH; Li N; Yang Z; Chen KN
    Dis Esophagus; 2013; 26(8):832-7. PubMed ID: 22947128
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical significance of ¹⁸F-fluorodeoxyglucose positron emission tomography in superficial esophageal squamous cell carcinoma.
    Kita Y; Okumura H; Uchikado Y; Sasaki K; Omoto I; Matsumoto M; Setoyama T; Tanoue K; Mori S; Owaki T; Ishigami S; Ueno S; Kajiya Y; Natsugoe S
    Ann Surg Oncol; 2013 May; 20(5):1646-52. PubMed ID: 23238695
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor/normal esophagus ratio in (18)F-fluorodeoxyglucose positron emission tomography/computed tomography for response and prognosis stratification after neoadjuvant chemotherapy for esophageal squamous cell carcinoma.
    Izumi D; Yoshida N; Watanabe M; Shiraishi S; Ishimoto T; Kosumi K; Tokunaga R; Taki K; Higashi T; Harada K; Miyata T; Ida S; Imamura Y; Iwagami S; Baba Y; Sakamoto Y; Miyamoto Y; Yamashita Y; Baba H
    J Gastroenterol; 2016 Aug; 51(8):788-95. PubMed ID: 26671045
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Discovery of the primary site of esophageal squamous cell carcinoma based on axillary lymph nodes metastasis detected with fluorodeoxyglucose positron-emission tomography: report of a case.
    Hagiwara N; Matsutani T; Nomura T; Miyashita M; Yamashita N; Wachi E; Uchida E
    J Nippon Med Sch; 2014; 81(6):395-400. PubMed ID: 25744485
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Parotid gland metastasis from squamous cell carcinoma of esophagus detected by FDG PET/CT.
    Hsieh TC; Wu YC; Sun SS; Yang CF; Kao CH
    Clin Nucl Med; 2012 Oct; 37(10):1001-2. PubMed ID: 22955076
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety of dose escalation by simultaneous integrated boosting radiation dose within the primary tumor guided by (18)FDG-PET/CT for esophageal cancer.
    Yu W; Cai XW; Liu Q; Zhu ZF; Feng W; Zhang Q; Zhang YJ; Yao ZF; Fu XL
    Radiother Oncol; 2015 Feb; 114(2):195-200. PubMed ID: 25586952
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of (18)F-fluorothymidine and (18)F-fluorodeoxyglucose PET/CT in delineating gross tumor volume by optimal threshold in patients with squamous cell carcinoma of thoracic esophagus.
    Han D; Yu J; Yu Y; Zhang G; Zhong X; Lu J; Yin Y; Fu Z; Mu D; Zhang B; He W; Huo Z; Liu X; Kong L; Zhao S; Sun X
    Int J Radiat Oncol Biol Phys; 2010 Mar; 76(4):1235-41. PubMed ID: 19910143
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictive value of nodal maximum standardized uptake value of pretreatment [18F]fluorodeoxyglucose positron emission tomography imaging in patients with esophageal cancer.
    Yap WK; Chang YC; Tseng CK; Hsieh CH; Chao YK; Su PJ; Hou MM; Yang CK; Pai PC; Lin CR; Hsieh CE; Wu YY; Hung TM
    Dis Esophagus; 2017 Aug; 30(8):1-10. PubMed ID: 28575243
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Colonic Metastasis From Esophageal Squamous Cell Carcinoma Demonstrated With 18F-FDG PET/CT.
    Fang N; Wang YL; Zeng L; Wu ZJ; Liu LL
    Clin Nucl Med; 2017 Jun; 42(6):456-457. PubMed ID: 28368888
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prediction of occult lymph node metastasis by metabolic parameters in patients with clinically N0 esophageal squamous cell carcinoma.
    Moon SH; Kim HS; Hyun SH; Choi YS; Zo JI; Shim YM; Lee KH; Kim BT; Choi JY
    J Nucl Med; 2014 May; 55(5):743-8. PubMed ID: 24700884
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Accurate FDG PET tumor segmentation using the peritumoral halo layer method: a study in patients with esophageal squamous cell carcinoma.
    Jun S; Park JG; Seo Y
    Cancer Imaging; 2018 Sep; 18(1):35. PubMed ID: 30257714
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical Significance of FDG-PET to Predict Pathologic Tumor Invasion and Lymph Node Metastasis of Superficial Esophageal Squamous Cell Carcinoma.
    Furukawa T; Hamai Y; Hihara J; Emi M; Yamakita I; Ibuki Y; Okada M
    Ann Surg Oncol; 2016 Nov; 23(12):4086-4092. PubMed ID: 27352201
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.